An experimental drug could provide relief for people suffering from cognitive effects of various stress-related disorders, such as post-traumatic stress disorder (PTSD), according to a new study conducted by Columbia University Medical Center (CUMC) researchers. The study, conducted in a PTSD mouse model, shows that an experimental drug called S107, one of a new class of small-molecule compounds called Rycals, prevented learning and memory deficits associated with ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment